Stocks to buy

We’re in the midst of a bear market. That’s something investors haven’t seen in quite some time. While many stocks are getting crushed, it does create an opportunity for patient buyers, especially with top blue-chip stocks to buy. While some may say it’s irresponsible to buy in an environment like this, I think it’s irresponsible

The U.S. stock market has been crashing all year long. In fact, year-to-date, the S&P 500 is down 23.3% through its first 184 trading days of the year. That makes 2022 the fourth-worst year in the stock market’s history. Against that backdrop, we’re all hoping things get better. Well… guess what? They will – and

Investors, including those who own green energy stocks, have myriad reasons to be bearish currently. Inflation remains high, with the year-over-year CPI registering 8.3% in August. The Fed responded as expected, raising interest rates by 0.75 percentage points, or 75 basis points, on Sept. 21.  That rate increase, the central bank’s third straight 75 basis-point

Although arguably most folks hate the political season due to the back-and-forth mudslinging that materializes, investors will want to pay close attention to the 2022 midterm elections. According to historical data, the midterms broadly kick off superior market performance. Per U.S. Bank’s wealth management arm, “When the analysts looked at data around midterm elections (elections

Some stocks under $10 are cheap for a reason, but there are other stocks under $10 that are solid long-term investments. There are all sorts of equities from which to choose when building your portfolio. While there are arguably great names at high prices, it’s important that investors don’t overlook quality stocks to buy for

[Editor’s note: “Prosper From Apple’s Major Upcoming Product Launch” was previously published in September 2022. It has since been updated to include the most relevant information available.] When Apple (AAPL) unveiled the first iPhone back in 2007, the late, great Steve Jobs implied that the iPod-lookalike with Blackberry-level functionality was a revolutionary product that would

It’s up for debate whether the overall stock market has hit a bottom, but many stocks have clearly become  oversold. That’s the case for many unknown and little-known stocks. Consequently, there are now plenty of unknown stocks to invest in that can climb tremendously. These types of stocks, which are mostly small-cap and micro-cap names,

Amid the economic chaos of 2022, investors have all but forgotten about VR and the once-promising metaverse. Since late 2021, Google search interest in the metaverse has collapsed by 88%. And stocks like Roblox (RBLX) and Meta (META) have been absolutely crushed. But maybe investors shouldn’t have forgotten about the metaverse. Maybe there’s something to

[embedded content] One of the best applications of virtual and extended reality (XR) is for work. And I fully expect consumers to interact with VR not with headsets, but with immersive experiences outside of the hardware currently on the market. Think of the iPhone and how it made smartphones ubiquitous – it was convenient. In

Amid all the market chaos, I’m busy doing one thing: looking for generational investment opportunities. Why? Because history shows that the best time to invest in emerging technological megatrends is when the markets are crashing. That’s exactly what they’re doing in 2022! The best time to invest in computer stocks? After the flash crash of

The latest market downturn has created several opportunities for investors to pick up high-quality, little-known stocks. That includes blue-chip stocks that have shed value since the beginning of the year. Granted, companies out of the mainstream spotlight tend to be riskier than larger counterparts. Nevertheless, the value of little-known stocks cannot be ignored as the

Finding the best meme stocks to buy can be a challenge. After all meme stocks are volatile by nature. Other than following meme stocks online, speculators cannot predict when they will surge. These meme stocks to buy all have been on the ropes but look as if they might have a recovery in their future.

If we look at the past few decades, the S&P 500 has witnessed some big crashes. However, the market has remained in an uptrend. The same holds true for industries that have multiyear tailwinds. Electric vehicle stocks have paused after a big rally. However, this growth story is still in the early stages. Therefore, I’ve

In financial markets, cash flows, growth outlook and valuation does matter. However, investor sentiment plays a key role in driving growth stocks higher or lower. When the economic outlook is positive and the financial system has ample liquidity, growth stocks tend to command a valuation premium. On the other hand, when the economic outlook weakens

Biotech stocks have performed relatively well compared to the broader market of late. The SPDR S&P Biotech ETF (NYSEARCA:XBI) is up 21% over the past three months compared with a 6% gain for the S&P 500. Biotech stocks have a reputation for being high-risk investments. The underlying firms spend a ton on research and development

Similar to other equities, battery stocks have taken quite a beating this year. Nonetheless, it remains a rapidly growing industry poised to deliver multi-bagger returns once the markets mount a comeback in the coming months. With the massive growth potential of the renewable energy market, investors are looking for various ways to get in on

Last week, a tentative deal was announced between unions and the railroad companies averting a national strike that could have seen 125,000 railroad workers go on strike. It also avoided a major economic disruption at a time when a recession remains a real possibility. Since the announcement of the deal on the morning of Sept.

Anti-aging stocks have not proven immune to poor market conditions that have plagued the broader biotech industry. The biotech industry remains hampered by the same bleak economic conditions as those affecting growth companies. As a result, the Nasdaq Biotechnology Index and SPDR S&P Biotech ETF (NYSEARCA:XBI) have fallen 16.5% and 23.5%, year to date (YTD),

Although the tail end of the third quarter brought some unwanted volatility to the market, forward-thinking investors might want to use this time to strategize undervalued stock picks. One of the primary benefits of this approach is that such securities may not have that much further to correct. That would appeal to risk-averse investors who

Until the summer of 2022, most financial traders didn’t spend much time thinking about 1life Healthcare (NASDAQ:ONEM) stock. They’re definitely paying attention now, though, as Amazon (NASDAQ:AMZN) is preparing to merge with 1life Healthcare. The merger deal’s not finalized yet, though. Therefore, sensible investors might choose to accumulate a few shares of ONEM stock but also